Clinical trial
Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer…
NCT00016978 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00016978 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan |
| Official title | A Phase II Study of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), and Leucovorin (CF) in Patients With Metastatic Colorectal Carcinoma Previously Treated With Irinotecan (CPT-11) |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | FOLFOX regimen, fluorouracil, leucovorin calcium, oxaliplatin |
| Enrollment | 40 |
| Start date | Apr 1, 2001 |
| Primary completion | Jun 1, 2007 |
| First posted | Mar 11, 2004 |
| Last update posted | Feb 5, 2013 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: